Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionVictory Capital Management Inc
Latest Disclosed Ownership35,447 shares
Latest Disclosed Value $ 512,564
Victory Capital Management Inc reports 89.80% decrease in ownership of FOLD / Amicus Therapeutics, Inc.

On May 15, 2026 - Victory Capital Management Inc filed a 13F-HR form disclosing ownership of 35,447 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $512,564 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 347,428 shares of Amicus Therapeutics, Inc.. This represents a change in shares of -89.80% during the quarter. The current value of the position is $513,627 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AMICUS THERAPEUTIC COM 03152W109 35,447 -311,981 -89.80 513 -89.65 0.0002
2026-02-13 2025-12-31 13F AMICUS THERAPEUTICS COM 03152W109 347,428 4,580 1.34 4,947 83.15 0.0028
2025-11-12 2025-09-30 13F AMICUS THERAPEUTICS COM 03152W109 342,848 239,367 231.31 2,702 356.25 0.0016
2025-08-13 2025-06-30 13F AMICUS THERAPEUTICS COM 03152W109 103,481 -153,607 -59.75 593 -71.77 0.0004
2025-05-02 2025-03-31 13F AMICUS THERAPEUTICS COM 03152W109 257,088 82,691 47.42 2,098 27.71 0.0021
2025-02-06 2024-12-31 13F AMICUS THERAPEUTICS COM 03152W109 174,397 -1,083,811 -86.14 1,643 -87.78 0.0016
2024-11-05 2024-09-30 13F AMICUS THERAPEUTICS COM 03152W109 1,258,208 -1,015,751 -44.67 13,438 -40.43 0.0129
2024-08-05 2024-06-30 13F AMICUS THERAPEUTICS COM 03152W109 2,273,959 345,117 17.89 22,558 -0.72 0.0226
2024-05-03 2024-03-31 13F AMICUS THERAPEUTICS COM 03152W109 1,928,842 176,155 10.05 22,722 -8.64 0.0222
2024-02-05 2023-12-31 13F AMICUS THERAPEUTICS COM 03152W109 1,752,687 -1,196,519 -40.57 24,871 -30.65 0.0262
2023-11-06 2023-09-30 13F AMICUS THERAPEUTICS COM 03152W109 2,949,206 2,350,262 392.40 35,862 376.76 0.0412
2023-07-27 2023-06-30 13F AMICUS THERAPEUTICS COM 03152W109 598,944 -1,311,824 -68.65 7,523 -64.50 0.0083
2023-05-02 2023-03-31 13F AMICUS THERAPEUTICS COM 03152W109 1,910,768 1,728,159 946.37 21,190 850.65 0.0238
2023-04-25 2022-12-31 13F/A-3 AMICUS THERAPEUTICS COM 03152W109 182,609 40,875 28.84 2,230 50.61 0.0026
2023-03-10 2022-12-31 13F/A-2 AMICUS THERAPEUTICS COM 03152W109 182,609 40,875 2,230 0.0015
2023-02-10 2022-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 182,609 40,875 2,230 0.0015
2023-02-09 2022-12-31 13F AMICUS THERAPEUTICS COM 03152W109 182,332 40,598 2,252 0.0015
2022-11-02 2022-09-30 13F AMICUS THERAPEUTICS COM 03152W109 141,734 54,584 62.63 1,480 58.12 0.0017
2022-08-01 2022-06-30 13F AMICUS THERAPEUTICS COM 03152W109 87,150 53,882 161.96 936 296.61 0.0011
2022-05-04 2022-03-31 13F AMICUS THERAPEUTICS COM 03152W109 33,268 -780 -2.29 236 -39.95 0.0002
2022-02-07 2021-12-31 13F AMICUS THERAPEUTICS COM 03152W109 34,048 63 0.19 393 20.92 0.0004
2021-11-02 2021-09-30 13F AMICUS THERAPEUTICS COM 03152W109 33,985 -1,232 -3.50 325 -4.13 0.0003
2021-08-03 2021-06-30 13F AMICUS THERAPEUTICS COM 03152W109 35,217 78 0.22 339 -2.31 0.0003
2021-05-04 2021-03-31 13F AMICUS THERAPEUTICS COM 03152W109 35,139 -3,154,913 -98.90 347 -99.53 0.0004
2021-02-01 2020-12-31 13F AMICUS THERAPEUTICS COM 03152W109 3,190,052 -635,449 -16.61 73,659 36.37 0.0821
2020-11-09 2020-09-30 13F AMICUS THERAPEUTICS COM 03152W109 3,825,501 317,779 9.06 54,016 2.12 0.0693
2020-08-07 2020-06-30 13F AMICUS THERAPEUTICS COM 03152W109 3,507,722 -497,762 -12.43 52,897 42.93 0.0716
2020-05-12 2020-03-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 4,005,484 -17,692 -0.44 37,010 -5.55 0.0621
2020-05-04 2020-03-31 13F AMICUS THERAPEUTICS COM 03152W109 4,005,484 -17,692 37,010 40,503.6842
2020-02-06 2019-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 4,023,176 355,292 9.69 39,185 33.21 0.0476
2020-02-04 2019-12-31 13F AMICUS THERAPEUTICS COM 03152W109 4,066,839 398,955 35,951 43,094.1274
2019-11-12 2019-09-30 13F AMICUS THERAPEUTICS COM 03152W109 3,667,884 15,425 0.42 29,416 -35.47 0.0378
2019-08-15 2019-06-30 13F AMICUS THERAPEUTICS COM 03152W109 3,652,459 548,730 17.68 45,583 7.99 0.0919
2019-05-03 2019-03-31 13F AMICUS THERAPEUTICS COM 03152W109 3,103,729 -45,120 -1.43 42,211 39.93 0.0960
2019-05-02 2018-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 3,148,849 -592,805 -15.84 30,166 -33.32 0.0757
2019-02-05 2018-12-31 13F AMICUS THERAPEUTICS COM 03152W109 3,148,849 -592,805 30,166
2018-11-01 2018-09-30 13F AMICUS THERAPEUTICS COM 03152W109 3,741,654 135,615 3.76 45,237 -19.69 0.0933
2018-08-02 2018-06-30 13F AMICUS THERAPEUTICS COM 03152W109 3,606,039 550,740 18.03 56,325 22.58 0.1199
2018-05-04 2018-03-31 13F AMICUS THERAPEUTICS COM 03152W109 3,055,299 410,375 15.52 45,951 20.73 0.1002
2018-02-01 2017-12-31 13F AMICUS THERAPEUTICS COM 03152W109 2,644,924 151,755 6.09 38,061 1.23 0.0801
2017-10-27 2017-09-30 13F AMICUS THERAPEUTICS COM 03152W109 2,493,169 -1,876,410 -42.94 37,597 -14.56 0.0845
2017-08-07 2017-06-30 13F AMICUS THERAPEUTICS COM 03152W109 4,369,579 -589,140 -11.88 44,002 24.45 0.1030
2017-05-10 2017-03-31 13F AMICUS THERAPEUTICS COM 03152W109 4,958,719 883,066 21.67 35,356 74.55 0.0842
2017-02-09 2016-12-31 13F AMICUS THERAPEUTICOM INC COM COM 03152W109 4,075,653 55,370 1.38 20,256 -31.91 0.0511
2016-11-02 2016-09-30 13F AMICUS THERAPEUTICOM INC COM COM 03152W109 4,020,283 4,020,283 29,750 0.0833
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.